iberdomide
bms
['iberdomide', 'mmsm', ' emd ']
responsiveness was seen in imid resistant, recently treated with pom. c/t iberdomide, mezi may be more potent therefore may be more potent in rrmm. cns penetration: no cns toxicity seen, but benefit is still being evaluated. benefit in emd has been seen. #ash22 #mmsm #myeloma
Hematology is in my ??. Posts are mine. Mayo Clinic Associate, Asst Prof, BMT RNCC, RN Navigator, emeritus. IMF NLB. MM KOL. Patient educator & advocate.